Provect - Model ABR - Aerobic Bioremediation Reagent - Brochure

Provect-IR™ (US patents 7,828,974; 8,147,694; patent pending) integrates a source of Monacolin K and other natural statins that inhibit the growth and proliferation of Archaea (i.e., methanogens) with multiple, controlled-release hydrophilic organic carbon sources and micro-scale zero-valent iron (ZVI) and other unique ingredients to yield in situ chemical reduction (ISCR), as defined by Dolfing et al (2008).